{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:30:59Z","timestamp":1792690259559,"version":"4.5.0"},"reference-count":35,"publisher":"Society of Nuclear Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.2967\/jnumed.115.165803","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T12:51:37Z","timestamp":1452862297000},"page":"872-878","source":"Crossref","is-referenced-by-count":243,"title":["<sup>68<\/sup>Ga-DOTATATE Compared with <sup>111<\/sup>In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis"],"prefix":"10.2967","volume":"57","author":[{"given":"Stephen A.","family":"Deppen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Blume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Bobbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirayu","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Delbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"2021051712091471000_57.6.872.1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ebaffd"},{"key":"2021051712091471000_57.6.872.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.4377"},{"key":"2021051712091471000_57.6.872.3","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.111.098277"},{"key":"2021051712091471000_57.6.872.4","first-page":"652","article-title":"Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide","volume":"33","author":"Krenning","year":"1992","journal-title":"J Nucl Med."},{"key":"2021051712091471000_57.6.872.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1989-4"},{"key":"2021051712091471000_57.6.872.6","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9631-1"},{"key":"2021051712091471000_57.6.872.7","doi-asserted-by":"publisher","DOI":"10.1177\/0284185113496679"},{"key":"2021051712091471000_57.6.872.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2482-z"},{"key":"2021051712091471000_57.6.872.9","first-page":"426","article-title":"The value of 68Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"4","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2021051712091471000_57.6.872.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2021051712091471000_57.6.872.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007753"},{"key":"2021051712091471000_57.6.872.12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-3-25"},{"key":"2021051712091471000_57.6.872.13","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v4.0. Publication No 09-5410. Bethesda, MD: National Institutes of Health; 2009."},{"key":"2021051712091471000_57.6.872.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-9485.2011.02327.x"},{"key":"2021051712091471000_57.6.872.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.066134"},{"key":"2021051712091471000_57.6.872.16","doi-asserted-by":"crossref","unstructured":"Deppen SA Liu E Blume JD . Safety and efficacy of 68Ga-DOTATATE PET\/CTfor diagnosis, staging and treatment management of neuroendocrine tumors. J Nucl Med. January 14, 2016 [Epub ahead of print].","DOI":"10.2967\/jnumed.115.163865"},{"key":"2021051712091471000_57.6.872.17","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-014-0856-3"},{"key":"2021051712091471000_57.6.872.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.144543"},{"key":"2021051712091471000_57.6.872.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.101675"},{"key":"2021051712091471000_57.6.872.20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122501"},{"key":"2021051712091471000_57.6.872.21","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23469"},{"key":"2021051712091471000_57.6.872.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.091165"},{"key":"2021051712091471000_57.6.872.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.111724"},{"key":"2021051712091471000_57.6.872.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-1030-8"},{"key":"2021051712091471000_57.6.872.25","doi-asserted-by":"crossref","unstructured":"Lastoria S Marciello F Faggiano A . Role of Ga-DOTATATE PET\/CT in patients with multiple endocrine neoplasia type 1 (MEN1). Endocrine. August 5, 2015 [Epub ahead of print].","DOI":"10.1007\/s12020-015-0702-y"},{"key":"2021051712091471000_57.6.872.26","doi-asserted-by":"publisher","DOI":"10.5603\/NMR.2011.0004"},{"key":"2021051712091471000_57.6.872.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2690-1"},{"key":"2021051712091471000_57.6.872.28","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-3981-2"},{"key":"2021051712091471000_57.6.872.29","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000533"},{"key":"2021051712091471000_57.6.872.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.142224"},{"key":"2021051712091471000_57.6.872.31","unstructured":"Walker RC . Imaging and treatment of neuroendocrine tumors. In: Nuclear Molecular Imaging and Therapy: Focus on Value. Baltimore, MD: Johns Hopkins University School of Medicine; 2014."},{"key":"2021051712091471000_57.6.872.32","doi-asserted-by":"crossref","unstructured":"Borenstein M Hedges LV Higgins JP Rothstein HR . Introduction to Meta-Analysis. 1st ed. West Sussex, United Kingdom: Wiley; 2009.","DOI":"10.1002\/9780470743386"},{"key":"2021051712091471000_57.6.872.33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.08.066"},{"key":"2021051712091471000_57.6.872.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.2553"},{"key":"2021051712091471000_57.6.872.35","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.114165"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.115.165803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:07:20Z","timestamp":1621282040000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.115.165803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,1]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.2967\/jnumed.115.165803"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.115.165803","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}